MedPath

TitelSymptom monitoring with patient-reported outcomes using a web application among lung cancer patients in the Netherlands (SYMPRO-LUNG )

Completed
Conditions
Lung cancer
Lung carcinoma
10027656
10029107
Registration Number
NL-OMON50136
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
584
Inclusion Criteria

Cytological or histologically proven or radiological suspect small or non-small
cell lung cancer patients that are starting treatment with radiotherapy,
surgery, chemotherapy, immunotherapy or targeted therapy, or a combination.
Other inclusion criteria are 18 years and older, ECOG Performance Status
classification should be 0,1 or 2 and access to internet.

Exclusion Criteria

Patients who are participants of a treatment study or when their life
expectancy at moment of inclusion is shorter than 15 weeks. The patient*s
treatment and follow up will have to remain in an affiliated hospital

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome is to measure the difference in QoL (EORTC QLQ C30 score),<br /><br>15 weeks after the start of the treatment.</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath